A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
Phase
2Span
109 weeksSponsor
H. Lundbeck A/SCampulung
Recruiting
1-1 of 1